http://archive.fast-edgar.com/20240429/A9BEB22CZ222K2ZP22292CZBGVM2ZS22Z262
Filed on: April 29, 2024
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of April 2024
Commission file number: 001-41598
YS BIOPHARMA CO., LTD.
(Exact name of registrant as specified in its charter)
Building No. 2, 38 Yongda Road
Daxing Biomedical Industry Park
The information in this preliminary prospectus supplement is not complete and may be changed. This preliminary prospectus supplement and the accompanying base prospectus do not constitute an offer to sell these securities and we are not soliciting offers to buy these securities in any jurisdiction where the offer or sale is not permitted.
Filed Pursuant to Rule 424(b)(5)Registration No. 333-266941
SUBJECT TO COMPLETION, DATED APRIL 28, 2024
More SEC Filings
View Older Stories-
Form 497K JNL SERIES TRUST
-
Form 8-K Douglas Elliman Inc. For: Apr 26
-
Form 8-K Owens Corning For: Apr 29
-
Form 25-NSE John Hancock Tax-Advanta Filed by: NEW YORK STOCK EXCHANGE LLC
-
Form 10-K/A CalciMedica, Inc. For: Dec 31
-
Form 10-K/A Altisource Asset Managem For: Dec 31
-
Form ARS Vital Farms, Inc. For: Dec 31
-
Form 8-K CPS TECHNOLOGIES CORP/DE For: Apr 25
-
Form 8-K Scorpius Holdings, Inc. For: Apr 29
-
Form 6-K Valens Semiconductor For: Apr 29
-
Form 485BPOS DAVIS SERIES INC
-
Form 8-K OGLETHORPE POWER CORP For: Apr 29
-
Form 8-K ON SEMICONDUCTOR CORP For: Apr 29
-
Form 10-D World Omni Automobile For: Mar 31
-
Form ARS Carisma Therapeutics For: Dec 31
-
Form D/A Lantah Co
-
Form DEFA14A Vital Farms, Inc.
-
Form 20-F Tuniu Corp For: Dec 31
-
Form 8-K COLLEGIUM PHARMACEUTICAL For: Apr 26
-
Form DEFA14A C4 Therapeutics, Inc.
-
Form 425 UMB FINANCIAL CORP Filed by: UMB FINANCIAL CORP
-
Form 10-Q NEWMONT Corp /DE/ For: Mar 31
-
Form 497K JNL SERIES TRUST
-
Form 10-K Namliong SkyCosmos, Inc. For: Dec 31
-
Form 6-K DAQO NEW ENERGY CORP. For: Apr 29
-
Form DEF 14A C4 Therapeutics, Inc. For: Apr 29
-
Form ARS Compass Therapeutics, For: Dec 31
-
Form DEF 14A Carisma Therapeutics For: Jun 13
-
Form 497K T. Rowe Price Equity
-
Form 497 T. Rowe Price Equity
-
Form 425 California BanCorp Filed by: Southern California Bancorp \ CA
-
Form DEFA14A Compass Therapeutics,
-
Form 8-K California BanCorp For: Apr 29
-
Form 20-F SunCar Technology Group For: Dec 31
-
Form ARS NOVAVAX INC For: Dec 31
-
Form DEF 14A Vital Farms, Inc. For: Jun 12
-
Form 1-K Sugarfina Corp For: Dec 31
-
Form 8-K Southern California Banc For: Apr 29
-
Form 6-K Enlivex Therapeutics For: Apr 29
-
Form 424B2 ROYAL BANK OF CANADA
-
Form 8-K UMB FINANCIAL CORP For: Apr 28
-
Form NT 20-F First High-School Educat For: Dec 31
-
Form 8-K Auto Parts 4Less Group, For: Apr 29
-
Form 8-K Aclarion, Inc. For: Apr 26
-
Form 8-K ALLIANCE RESOURCE PARTNE For: Apr 29
-
Form 10-K/A CBAK Energy Technology, For: Dec 31
-
Form 8-K Innovative Eyewear Inc For: Apr 28
-
Form 8-K Mosaic ImmunoEngineering For: Apr 26
-
Form 8-K Ocugen, Inc. For: Apr 26
-
Form DEF 14A Plymouth Industrial REIT For: Jun 27